Establishing Normal Values for Neuropsychological Testing in HIV-negative Thais
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to establish normal values for neuropsychological testing in HIV negative Thais stratified by age (1 decade) and education (no certificate or primary school certificate, less than high school certificate or vocational certificate, high school certificate or higher vocational certificate or diploma, Bachelor degree or higher.
| Condition |
|---|
|
HIV Infections |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Estimated Enrollment: | 440 |
| Study Start Date: | February 2008 |
| Estimated Study Completion Date: | October 2012 |
| Estimated Primary Completion Date: | July 2012 (Final data collection date for primary outcome measure) |
The Southeast Asia Research Collaboration with Hawaii (SEARCH) operates or collaborates on several neuroAIDS research protocols. To allow accurate interpretation of neuropsychological data, normative data that are obtained in a similar population are needed. Currently, there are limited such data available for this purpose.
The SEARCH 001 study evaluated the neurocognitive changes before and after highly active antiretroviral therapy in 30 HIV positive subjects and has also enrolled 230/300 proposed HIV-negative controls for this purpose. Normative data tables typically require many more individuals so that age and education strata can be established. We now propose to enroll up to 1000 HIV-seronegative individuals for this purpose.
Eligibility| Ages Eligible for Study: | 20 Years to 69 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
HIV-negative Thais
Inclusion Criteria:
- Age 20-69
- Male or female
- Negative HIV antibody at screening
- Have the ability to understand the study and signed the informed consent form
Exclusion Criteria:
- Head injury with loss of consciousness greater than 1 hour
- Current or past illicit drug use or positive drug screen for amphetamine, methamphetamines, cocaine, marijuana, or narcotics
- Severe illness within 30 days prior to entry
- Current or recent fevers or meningeal signs.
- History of pre-existing neurologic disease to include stroke, multiple sclerosis or autoimmune disease.
- active major depression will be excluded as well - patients with past depression that is controlled and patients with or minor depressive symptoms will be allowed to enroll.
- Known learning disability including dyslexia
- Confusion or other signs and symptoms of metabolic encephalopathy or delirium
- Focal neurological deficit on examination
- Examining physician's concern that participant may not be able to complete visit requirements.
Contacts and Locations| Contact: Jintanat - Ananwaoranich, M.D. | 662-254-2566 ext 1 | jintanat.a@searchthailand.org |
| Contact: Somporn - Tipsuk, BNS | 662-254-2568-9 ext 107 | somporn.t@searchthailand.org |
| Thailand | |
| SEARCH Thailand | Recruiting |
| Bangkok, Thailand, 10330 | |
| Contact: Somporn - Tipsuk, BNS 6622542566 ext 107 somporn.t@searchthailand.org | |
| Principal Investigator: | Victor - Valcour, M.D. | University of Hawaii |
More Information
No publications provided
| Responsible Party: | Somprartthana Rattanamanee, SEARCH Thailand |
| ClinicalTrials.gov Identifier: | NCT00713752 History of Changes |
| Other Study ID Numbers: | SEARCH002 |
| Study First Received: | July 8, 2008 |
| Last Updated: | April 29, 2011 |
| Health Authority: | Thailand: Ministry of Public Health |
Keywords provided by South East Asia Research Collaboration with Hawaii:
|
HIV-negative |
Additional relevant MeSH terms:
|
HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases |
ClinicalTrials.gov processed this record on June 17, 2013